LFVN — what changed in the latest 10-K
A section-by-section comparison of LFVN's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-K · 2026-08-27 vs the prior 10-K · 2025-09-04
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| Business | Text added/removed | +49 | −69 | ~58 | 79 |
| Risk factors | Text added/removed | +34 | −20 | ~52 | 109 |
| MD&A | Text added/removed | +22 | −26 | ~28 | 27 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Market risk (Item 7A)
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
Business
Text added vs the prior filing · source: 10-K · 2026-08-27
In fiscal year 2026, following the acquisition of the critical operating assets of LoveBiome in October 2025, we launched the P84 System, PhytoPower B, AXIO® X and AXIO® Hydrate in the United States. We also introduced Healthy Edge, a new product pack combining Protandim® Nrf2 Synergizer® and the P8…
In the United States, we launched four products acquired from LoveBiome following our October 2025 acquisition of its critical operating assets. These product launches included: the P84 System, a two product system consisting of PhytoPower 1 and PhytoPower 2 that includes probiotics, prebiotics, pos…
250 mg of natural caffeine and functional ingredients to support stamina and physical energy that was rebranded and launched as AXIO® X; and Next Hydrate, a mango lemonade-flavored electrolyte drink mix formulated to support hydration, recovery, and performance that was rebranded and launched as AXI…
In Japan, we launched the TrueScience® TrueRefine Mask during the holiday season and introduced a limited-edition AXIO® Decaffeinated Peach Nectarine flavor.
In Taiwan, we launched the P84 System in February 2026 and offered the TrueScience® TrueRefine Glow-Up Mask as a limited-time promotion in April 2026.
Text removed vs the prior filing · source: 10-K · 2025-09-04
In fiscal year 2025, we launched the next evolution in activation, the patent-pending MindBody GLP-1 System™ consisting of MB Core™ and MB Enhance™. With ingredients backed by science and formulas designed to support the body’s natural production of the GLP-1 hormone, the MindBody GLP-1 System™ help…
•In the United States, we introduced the MindBody GLP-1 System™ and an event-exclusive AXIO® limited-edition Tiger’s Blood flavor at our Global Convention in Salt Lake City, Utah. The United States also reintroduced AXIO® Decaf Peach Nectarine as a permanent flavor, TrueScience® TruePout Hydrating L…
•In Japan, we introduced the MB System™ (an international formulation of the MindBody GLP-1 System™ ) and reintroduced TrueScience® TrueProtect as a limited-edition item during the summer months.
•In Australia and New Zealand, we introduced the MB System™ and TrueScience® Hand Cream in Mango Blossom, available exclusively through the Rewards Circle loyalty program.
•In Canada, we introduced Protandim® NAD Synergizer® and a clean, caffeinated AXIO® in Dragon Fruit flavor.
Risk factors
Text added vs the prior filing · source: 10-K · 2026-08-27
Because we have expanded into foreign countries, our policies and procedures for our independent consultants differ slightly in some countries due to the different legal requirements of each country in which we do business. In addition, as we have expanded internationally, some of our independent co…
have taken steps to stop or restrict these sales from occurring, including through our independent consultant policies and procedures, it can be difficult to enforce these policies and procedures because of the large number of independent consultants and their independent status. If relevant regulat…
Raw materials account for a significant portion of our manufacturing costs, and we rely on third-party suppliers to provide raw materials. Suppliers may be unable or unwilling to provide the raw materials our manufacturers need in the quantities requested, at a price we are willing to pay, or that m…
of the raw materials used in the manufacturing of our products that meets our quality standards. Additionally, if demand for our products exceeds our forecasts, we may have difficulties in obtaining additional raw materials in time to meet the excess demand. Any significant delay in or disruption of…
Publicly traded companies have increasingly become subject to campaigns by activist investors advocating for corporate actions such as financial restructurings, increased borrowings, special dividends, stock repurchases or even sales of assets or entire companies to third parties or the activists th…
Text removed vs the prior filing · source: 10-K · 2025-09-04
Because we have expanded into foreign countries, our policies and procedures for our independent consultants differ slightly in some countries due to the different legal requirements of each country in which we do business. In addition, as we have expanded internationally, some of our independent co…
Raw materials account for a significant portion of our manufacturing costs, and we rely on third-party suppliers to provide raw materials. Suppliers may be unable or unwilling to provide the raw materials our manufacturers need in the quantities requested, at a price we are willing to pay, or that m…
Publicly traded companies have increasingly become subject to campaigns by activist investors advocating for corporate actions such as financial restructurings, increased borrowings, special dividends, stock repurchases or even sales of assets or entire companies to third parties or the activists th…
marketing commences in a new country or market, it is difficult to assess the extent to which our products and sales techniques will be accepted or successful. In addition to significant regulatory barriers, we may also encounter problems conducting operations in new markets with different cultures …
We depend on our IT systems to manage numerous aspects of our business, including our finance and accounting transactions, to manage our independent consultant sales compensation plan and to provide analytical information to management. Our IT systems are an essential component of our business and g…
MD&A
Text added vs the prior filing · source: 10-K · 2026-08-27
was specifically formulated to target cell signaling pathways involved in the synthesis and recycling of a specific molecule called NAD (nicotinamide adenine dinucleotide), and it has been shown to double sirtuin activity, supporting increased health, focus, energy, mental clarity, and mood. Use of …
The LifeVantage® product line includes: the MindBody GLP-1 System®, a dietary supplement that combines two products MB Core® and MB Enhance® designed to support weight loss and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Omega+, a dietary supplement that co…
The P84 System is our newest patent pending two-product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health, which, in an in vitro study, activated 14 key gut peptides associat…
We sell our products both individually and in stacks. A stack consists of multiple products bundled together that are designed to achieve a specific result. In fiscal year 2026, our stack strategy continued to focus on the brand message of activation. As part of the launch of our latest activator, t…
indicated. The following table should be reviewed in connection with the tables presented under “Results of Operations” (in thousands):
Text removed vs the prior filing · source: 10-K · 2025-09-04
The LifeVantage® product line includes: the new MindBody GLP-1 System™, a dietary supplement that combines two products MB Core™ and MB Enhance™ designed to support weight loss and wellness by activating GLP-1 naturally and
balancing signals along the gut-brain axis; Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, omega-7 fatty acids, and vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system; ProBio, a dietary supplement designed to support optimal…
PhysIQ™ Fat Burn is a dietary supplement designed to support weight management, and PhysIQ™ Prebiotic is a dietary supplement designed to support a healthy digestive tract.
We sell our products both individually and in stacks. A stack consists of multiple products bundled together that are designed to achieve a specific result. In fiscal year 2025, our stack strategy continued to focus on the brand message of activation. During the year, we introduced a number of new s…
We also introduced our Healthy Weight Stack, which includes the MindBody GLP-1 System™ and Protandim® Nrf2 Synergizer®. Results of an in vitro study were released that showed beneficial “activation synergies” when both products were used together, including enhanced fatty acid metabolism, improved d…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice